title: Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Linden
authors.forename: Veronika
authors.initials: V
authors.lastname: Bachanova
authors.forename: Zohar
authors.initials: Z
authors.lastname: Sachs
authors.forename: Jo-Anne H
authors.initials: JA
authors.lastname: Young
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Singleton
authors.forename: Celalettin
authors.initials: C
authors.lastname: Ustun
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived / Q000276:immunology* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D004342:Drug Hypersensitivity / Q000276:immunology*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D000069283:Rituximab; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; C527517:ofatumumab